Central Nervous System Tumor

Exclusive breastfeeding for at least 3 months was associated with reduced childhood hematologic cancer risk vs. shorter breastfeeding durations, according to cohort study results published in JAMA Network Open.

Jessica Clymer, MD, has been appointed director of pediatric neuro-oncology at Hassenfeld Children’s Hospital at NYU Langone.

The FDA granted orphan drug designation to silmitasertib for treatment of medulloblastoma.

Brain and central nervous system tumors are the second most common malignancy among children and the most prevalent form of solid tumor, according to American Cancer Society data.

The FDA granted fast track designation to tozuleristide for treatment of pediatric central nervous system tumors.